PESI presents a deteriorating liquidation posture as of March 31, 2026. Under the liquidation lens, haircutted assets total approximately $43-46M against face-value liabilities of $38.7M, yielding thin-to-negative equity recovery depending on PP&E realization. Cash of $6.7M recovers at par. AR (billed $9.2M + unbilled $8.0M, net of $0.3M allowance) recovers at 90-95%, or roughly $15.4-16.3M. Inventory of $1.9M at 60% yields $1.1M. PP&E net book value of $25.0M (gross $58.4M, accumulated depreciation $33.4M) at a 50-60% haircut yields $12.5-15.0M. Indefinite-lived intangibles (operating permits) of $10.75M and finite intangibles net $0.5M are assigned zero recovery value under the liquidation lens; these are not separately transferable without the underlying licensed operations and would carry significant closure and remediation liabilities in a wind-up. Restricted cash of $13.3M (finite risk sinking funds) recovers at par but is encumbered: it supports facility closure/post-closure obligations and standby letters of credit; net free recovery is constrained by the corresponding closure liability obligations discussed below. Total liabilities at face value are $38.7M, but this understates true wind-up obligations. Environmental remediation liabilities (discontinued operations) total $3.47M; closure and post-closure requirements for Treatment Segment facilities secured through AIG financial assurance total approximately $24.55M per the MD&A — this obligation is not separately XBRL-tagged and does not appear on the balance sheet as a liability, but in a liquidation scenario these obligations survive and would consume a significant portion of restricted cash and potentially more. The PNC Credit Facility matures May 2027; outstanding balance on Term and Capital Loans is $1.78M; the $12.5M revolving facility had zero drawn as of period end but $3.35M in standby letters of credit outstanding reduce borrowing availability. The filing discloses a going concern qualification, with Liquidity declining from $18.1M at December 31, 2025 to $10.7M at March 31, 2026 — a $7.4M draw in one quarter driven by operating losses of $7.5M pre-tax and $0.9M in capex/investing cash outflows net of financing. Operating losses accelerated: Q1 2026 operating loss was $7.5M versus $3.7M in Q1 2025, a 100% deterioration. Gross margin went from positive 4.7% to negative 25.9% in one year. COGS exceeded revenue by $2.9M. Full valuation allowance on deferred tax assets established in Q3 2024 forecloses any tax asset recovery. A material weakness in internal controls over revenue recognition was identified and remains unremediated. Post-period NOV received from Washington State DOE at the PFNWR facility adds unquantified regulatory tail risk. The filing discusses the $24.55M AIG-secured closure/post-closure obligation and $12.3M in bonds outstanding in MD&A but does not separately XBRL-tag these as balance sheet liabilities, which understates the face-value liability stack under the liquidation lens.
▼ Community Notes